ChartRow logo
TDOC
$6.21+8.38%
as of close, Oct 20, 2026
☾ AH $6.21 +8.38%
PeersBTSGVEEVSPYQQQNVDAAAPL
Share this page

TDOC financial statements

The full income statement, balance sheet, and cash-flow statement for Teladoc Health Inc. (TDOC), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 171.2M2024-09 172.2M2024-12 173.7M2025-03 175.4M2025-06 176.7M2025-09 177.5M2025-12 178.4M2026-03 180.5M2026-06 181.7M+6.1% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.53B-1.5%2.57B-1.3%2.60B+8.1%2.41B+18.4%2.03B+85.8%
Cost of revenue———744M+14.4%650M+66.4%
Research & development278M-9.6%307M-11.8%349M+4.5%334M+7.0%312M+89.1%
Selling, general & administrative432M-0.8%435M-6.3%465M+3.3%450M+2.7%438M-13.6%
General & administrative432M-0.8%435M-6.3%465M+3.3%450M+2.7%438M-13.6%
Restructuring18.8M-7.7%20.4M+20.1%16.9M+128.5%7.42M—
Amortization of intangibles351M-3.5%363M+11.5%326M+33.2%245M+25.3%195M+201.9%
Provision for credit losses1.00K-100.0%3.79M-19.0%4.69M+66.5%2.81M-73.5%10.6M+100.7%
Operating income-263M+74.2%-1.02B-310.7%-249M+98.2%-13.7B-5039.9%-266M+47.5%
Interest expense19.7M-17.2%23.8M+6.8%22.3M+1.5%21.9M-73.0%81.1M
Interest & investment income36.8M-35.6%57.1M+22.0%46.8M+269.1%12.7M+1533.2%776K
Net interest income———-9.27M+88.5%-80.4M-34.1%
Other non-operating income10.4M+271.8%-6.04M-235.8%4.45M+617.5%-859K-116.9%5.09M+1033.6%
Pre-tax income-236M+76.3%-994M-352.5%-220M+98.4%-13.7B-3452.1%-385M+33.2%
Income tax-35.2M-563.8%7.59M+898.9%760K+119.9%-3.81M-108.6%44.1M+148.6%
Net income-200M+80.0%-1.00B-354.4%-220M+98.4%-13.7B-3085.6%-429M+11.6%
-$1.14+80.6%-$5.87-338.1%-$1.34+98.4%-$84.60-2998.9%-$2.73+49.1%
EPS (basic)-$1.14+80.6%-$5.87-338.1%-$1.34+98.4%-$84.60-2998.9%-$2.73+49.1%
Weighted-avg shares (basic)176M+3.3%171M+3.6%165M+1.9%161M+2.9%157M+73.4%
Weighted-avg shares (diluted)176M+3.3%171M+3.6%165M+1.9%161M+2.9%157M+73.4%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.12B-32.7%1.66B+11.7%1.49B+13.2%1.32B+7.3%1.23B+15.7%
Cash & equivalents781M-39.8%1.30B+15.5%1.12B+22.4%918M+2.8%893M+21.8%
Accounts receivable193M-10.0%214M-1.5%217M+3.3%211M+24.6%169M-0.2%
Inventory38.2M+0.2%38.1M+29.2%29.5M-47.6%56.3M-22.9%73.1M+29.3%
Prepaid expenses107M-5.5%113M-4.3%118M-9.1%130M+49.1%87.4M+84.9%
Other current assets2.07M-26.8%2.83M-62.0%7.44M-38.5%12.1M+113.9%5.66M
2.86B-18.7%3.52B-19.9%4.39B+1.1%4.35B-75.5%17.7B-0.1%
Property, plant & equipment27.0M-8.5%29.5M-7.9%32.0M+8.1%29.6M+8.8%27.2M-4.6%
Operating lease right-of-use26.1M-3.6%27.1M-32.4%40.1M-4.2%41.8M-10.6%46.8M+0.3%
Goodwill283M+0.0%283M-73.6%1.07B+0.0%1.07B-92.6%14.5B-0.5%
Intangible assets1.30B-9.4%1.43B-14.7%1.68B-8.7%1.84B-3.8%1.91B-5.5%
Other non-current assets106M+29.8%81.5M+1.5%80.3M+65.3%48.5M+134.5%20.7M+12.8%
405M-57.0%942M+123.8%421M+5.2%400M+20.8%331M-0.5%
Accounts payable48.0M+44.8%33.1M-24.1%43.6M-8.5%47.7M+0.9%47.3M+2.7%
Deferred revenue62.3M-21.4%79.3M-17.1%95.7M-6.1%102M+34.8%75.6M+44.3%
Short-term & current debt
————0.00-100.0%
Current lease liability11.0M+6.8%10.3M-3.9%10.8M-20.9%13.6M+7.1%12.7M+10.9%
Other current liabilities20.4M-25.5%27.4M-20.1%34.3M-17.5%41.6M+54.4%27.0M+29.1%
1.47B-27.3%2.03B-2.0%2.07B——
Deferred revenue (non-current)9.14M-6.6%9.79M-28.2%13.6M+14.0%12.0M+211.8%3.83M+56.6%
Non-current lease liability34.2M+6.4%32.1M-25.0%42.8M+12.6%38.0M-8.9%41.8M-3.2%
Operating lease liability (total)45.2M+6.5%42.5M-20.7%53.6M+3.8%51.6M-5.2%54.5M-0.2%
Deferred tax liabilities28.9M-41.9%49.9M+0.8%49.5M-2.9%50.9M-32.8%75.8M-25.8%
Other non-current liabilities643K-10.7%720K-33.3%1.08M-33.3%1.62M+8.4%1.49M-7.7%
1.39B-7.1%1.49B-35.9%2.33B+0.8%2.31B-85.6%16.0B+1.0%
Common stock178K+2.9%173K+3.6%167K+2.5%163K+1.9%160K+6.7%
Additional paid-in capital17.9B+0.5%17.8B+1.0%17.6B+1.3%17.4B-0.7%17.5B+3.7%
Retained earnings-16.4B-1.2%-16.2B-6.6%-15.2B-1.5%-15.0B-955.8%-1.42B-43.2%
Accumulated other comprehensive income-34.7M+9.5%-38.4M-3.8%-37.0M+13.5%-42.8M-580.6%-6.29M-133.9%
Total liabilities & equity2.86B-18.7%3.52B-19.9%4.39B+1.1%4.35B-75.5%17.7B-0.1%
Common shares issued178M+2.8%173M+4.0%167M+2.3%163M+1.5%160M+6.8%
Common shares outstanding178M+2.8%173M+4.0%167M+2.3%163M+1.5%160M+6.8%
Shares outstanding (cover)178M+2.7%174M+4.0%167M+2.7%163M+1.4%160M+5.0%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
294M+0.2%294M-16.1%350M+84.9%189M-2.4%194M+462.5%
Depreciation & amortization———256M+25.4%204M+193.9%
Intangible amortization351M-3.5%363M+11.5%326M+33.2%245M+25.3%195M+201.9%
Share-based compensation80.4M-44.9%146M-27.6%202M-7.5%218M-28.0%303M-36.4%
Deferred income taxes-41.4M-3516.3%-1.15M+39.9%-1.90M+75.7%-7.84M-119.1%41.0M+145.3%
Change in receivables-25.1M-6800.3%375K-96.3%10.3M-79.1%49.1M+339.1%11.2M-47.0%
Change in inventory-399K-104.1%9.75M+140.5%-24.1M-62.8%-14.8M-175.9%19.5M-21.2%
Change in payables11.5M+210.5%-10.4M-147.7%-4.18M-323.1%1.88M+57.9%1.19M+101.4%
-266M-114.4%-124M+20.7%-156M+6.8%-168M-129.8%-73.0M+87.7%
Capital expenditure8.89M-17.6%10.8M-5.9%11.5M-30.4%16.5M+93.1%8.53M+112.1%
Free cash flow285M+0.9%283M-16.4%339M+95.9%173M-6.8%185M+422.3%
Acquisitions81.9M0.000.000.00-100.0%78.7M-86.1%
Purchases of investments27.9M0.000.00——
Other investing activities-60.0K0.00+100.0%-1.00K+100.0%-2.51M+71.2%-8.71M
-552M-6736.8%8.31M-23.4%10.9M+67.1%6.50M-84.1%40.9M-95.2%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased0.000.000.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities0.00+100.0%-2.00K+99.3%-278K+95.3%-5.89M-16.2%-5.07M
FX effect on cash6.05M+284.2%-3.29M-440.7%965K+128.9%-3.34M-85.8%-1.80M-141.7%
Interest paid15.0M-13.4%17.3M-0.6%17.4M+0.4%17.4M-7.8%18.8M+26.5%
Income taxes paid8.74M-2.2%8.95M+23.6%7.24M+188.1%2.51M-36.8%3.97M+200.2%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.25B-20.9%1.58B-55.8%3.57B-6.8%3.83B-74.0%14.7B-51.8%
P/S0.5×-19.7%0.6×-55.6%1.4×-16.1%1.6×-77.2%7.2×-74.1%
P/B0.9×-14.9%1.1×-31.9%1.6×+145.8%0.6×-31.0%0.9×-52.3%
P/FCF4.4×-21.6%5.6×-57.9%13.3×-33.0%19.8×-75.1%79.4×
FCF yield22.9%+27.6%17.9%+137.5%7.5%+49.2%5.1%+301.6%1.3%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TDOC’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TDOC filings on SEC EDGAR → Not investment advice.